logo & slogan

Member Log In


Password

Sign Up
About

     Life SciencesClean Tech                                SearchUpload

  





 

 

THE STATE OF CHINA BIOTECH

Facts and Figures from ChinaBio
Part II - Technology Development and Clinical Trial Activity
Recorded on: January 13, 2009
Runtime: 00:08:02

There has been much debate on the state of new drug development in China. Are there novel molecules being discovered there? What is the level of clinical trial activity? Are VCs investing in China? What about M&A and IPOs?

Greg Scott, President of ChinaBio, presents research data for 2008 for the first time, at an executive workshop held at Wilson Sonsini Goodrich & Rosati in San Francisco during the JP Morgan 27th Annual Healthcare Conference.

This segment focuses on technology development as manifested by patent trends - analyzed by indication, sources and location; and on clinical trial activity and current status.

Tags: China, ChinaBio, Greg Scott, China biotech, clinical trial


"The BioPharma Business in China - Part I"
Research Findings from ChinaBio


"The BioPharma Business in China - Part II"
Research Findings from ChinaBio


"The BioPharma Business in China - Part III"
Research Findings from ChinaBio


"China - Half Way Up the Value Chain"
Conversation with Charles Hsu, Part I


"Surviving Tough Times"
Conversation with Charles Hsu, Part II


"The System Is Not Optimal!"
Conversation with Charles Hsu, Part III


"Nanotech Aiding Fight Against Cancer"
Senator Feinstein Video Address